Our Mission

Hacking Complex Diseases and Aging with AI for Drug Discovery and Digital Biomarkers

Learn more

GERO.AI models are originating from the physics of complex dynamic systems. We have presented our unique approach in Frontiers in Genetics. We combine the potential of deep neural networks with the physical models to study dynamical processes and undersend what drives a disease.

Gero conducts high-quality research studies backed by collaboration with researchers from the leading global institutions to develop new therapies. Those institutions include:

25

Diseases

Our Team
Gero is founded by AI champions, including AIMATTER founders (recently acquired by Google)
In 2019, Gero was also named one of the leading companies in artificial intelligence for lifespan extension along with Google and IBM

25

Diseases

Peter Fedichev
CEO. Co-founder at Gero
Curing the incurable with Landau Lifshitz book and a bit of AI
Maxim Kholin
Co-founder at Gero
I am doing my best to make aging a history
Alex Kadet
Head of Business Development
On a mission to fund science against aging
Kirill Denisov
Junior Deep Learning Researcher
Understanding the Universe,
while providing real-world solutions
Olga Burmistrova
Ph.D., Head of Preclinical Development
Konstantin Avchaciov
Data scientist - Life extension research
Data Inquisitor
Ilya Sokolov
Data Scientist
Data Inquisitor
Olga Druzhinina
Deputy Finance Director
Right-hand-woman to aging hackers
Key Collaborators
Robert J. Shmookler
Reis, PhD
Longevity pioneer, Professor and Udupa Chair in Geriatrics, Reynolds Institute on Aging/ Dept. of Geriatrics; Professor of Biochemistry/ Molecular Biology and Pharmacology/ Toxicology, Univ. of Arkansas for Medical Sciences.
Brian Kennedy, PhD
Distinguished Professor of Biochemistry and Physiology, Yong Loo Lin School of Medicine, NUS, Singapore, Buck Institute for Research on Ageing, Novato, CA, USA.



Andrei Gudkov, PhD
Senior Vice President of Research Programming and Development of Roswell Park Cancer Institute. CSO of Everon Biosciences, founded in 2010 in a partnership with Roswell Park Cancer Institute with the goal of developing anti-aging medicines.
Vadim Gladyshev, PhD
Professor of Medicine, professor at Harvard Medical School & Brigham and Women's Hospital. Expert and pioneer in antioxidant/redox biology.




Yuri Aulchenko, PhD
CSO and Founder of Poly Omica Honorary Professor of the University of Edinburgh, listed among "The World's Most Influential Scientific Minds" in the category "Molecular Biology & Genetics" by Thomson-Reuters.

Careers in GERO.AI
We are a next-gen AI for Drug Discovery company making cutting-edge science and continuously looking for great people to join a fast-growing team of like-minded pioneers to solve some of the most critical problems humanity faces
GERO.AI models are originating from the physics of complex dynamic systems. We have presented our unique approach in Frontiers in Genetics. We combine the potential of deep neural networks with the physical models to study dynamical processes and undersend what drives a disease.
Gero conducts high-quality research studies backed by collaboration with researchers from the leading global institutions to develop new therapies. Those institutions include:
Gero is founded by AI champions, including AIMATTER founders (recently acquired by Google)
In 2019, Gero was also named one of the leading companies in artificial intelligence for lifespan extension along with Google and IBM
Our Team
Peter Fedichev
CEO. Co-founder at Gero
Curing the incurable with Landau Lifshitz book and a bit of AI
Alex Kadet
Head of Business Development
Science is a pricey thing.
On a mission to fund science against aging
Maxim Kholin
Co-founder at Gero
I am doing my best to make aging
a history
Kirill Denisov
Junior Deep Learning Researcher
Understanding the Universe,
while providing real-world solutions
Konstantin Avchaciov
Data scientist - Life extension research
Data Inquisitor
Olga Burmistrova
Ph.D., Head of Preclinical Development
Ilya Sokolov
Data Scientist
Olga Druzhinina
Deputy Finance Director
Right-hand-woman
to aging hackers
Key Collaborators
Robert J. Shmookler
Reis, PhD
Longevity pioneer, Professor
and Udupa Chair in Geriatrics, Reynolds Institute on Aging/Dept. of Geriatrics; Professor of Biochemistry/Molecular Biology and Pharmacology/Toxicology, Univ. of Arkansas for Medical Sciences
Brian Kennedy, PhD
Distinguished Professor
of Biochemistry and Physiology, Yong Loo Lin School of Medicine, NUS, Singapore, Buck Institute
for Research on Ageing, Novato, CA, USA.
Andrei Gudkov, PhD
Senior Vice President of Research Programming and Development
of Roswell Park Cancer Institute. CSO of Everon Biosciences, founded in 2010 in a partnership with Roswell Park Cancer Institute with the goal of developing anti-aging medicines.
Vadim Gladyshev, PhD
Professor of Medicine, professor
at Harvard Medical School
& Brigham and Women's Hospital. Expert and pioneer in antioxidant/redox biology
Yuri Aulchenko, PhD
CSO and Founder of Poly Omica Honorary Professor of the University
of Edinburgh, listed among "The World's Most Influential Scientific Minds"
in the category "Molecular Biology & Genetics"by Thomson-Reuters.
Careers in GERO.AI
We are a next-gen AI for Drug Discovery company making cutting-edge science
and continuously looking for great people
to join a fast-growing team of like-minded pioneers to solve some of the most critical problems humanity faces
We are looking for:
Machine Learning Research Scientist
Software Engineer
Machine Learning Engineer
Business Development Associate (US)
Business Development Associate (EU)
Business Development Associate (APAC)
Contact us
We are looking for:
Machine Learning
Research Scientist
Software Engineer
Machine Learning
Engineer
Business Development
Associate (US)
Business Development
Associate (EU)
Business Development
Associate (APAC)
Contact us
Contacts
Contact us
Partnership and collaboration
Job opportunities
Stay updated on Gero news!
Contacts
Contact us
Partnership and collaboration
Job opportunities
Stay updated
on Gero news!